Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2451
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.78M | ﹤0.01% |
108,935
+66,851
| +159% | +$1.11M |
|
2452
ITT
ITT
$17.5B
| $1.78M | ﹤0.01% |
17,384
-59,884
| -78% | -$5.86M |
|
|
PRA
2453
DELISTED
ProAssurance
PRA
| $1.78M | ﹤0.01% |
70,227
+19,463
| +38% | +$464K |
|
|
SILK
2454
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.78M | ﹤0.01% |
41,685
+27,819
| +201% | +$1.39M |
|
2455
Byline Bancorp
BY
$1.78B
| $1.77M | ﹤0.01% |
64,800
+34,180
| +112% | +$901K |
|
2456
PUT
Inspire Medical Systems
INSP
$1.45B
| $1.77M | ﹤0.01% |
+7,700
| New | +$1.88M |
|
|
COWN
2457
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.77M | ﹤0.01% |
48,964
-1,055
| -2% | -$38.7K |
|
2458
CALL
Incyte
INCY
$24.2B
| $1.76M | ﹤0.01% |
+24,000
| New | +$1.62M |
|
2459
Kura Oncology
KURA
$800M
| $1.76M | ﹤0.01% |
125,646
+42,711
| +51% | +$692K |
|
|
SRNE
2460
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.76M | ﹤0.01% |
378,429
+242,451
| +178% | +$1.51M |
|
|
SCS
2461
DELISTED
Steelcase
SCS
| $1.76M | ﹤0.01% |
150,042
+69,339
| +86% | +$836K |
|
2462
CALL
Stratasys
SSYS
$679M
| $1.75M | ﹤0.01% |
71,600
| – | – |
|
2463
Primoris Services
PRIM
$4.58B
| $1.75M | ﹤0.01% |
72,952
+25,596
| +54% | +$647K |
|
2464
NETGEAR
NTGR
$648M
| $1.75M | ﹤0.01% |
59,785
+15,550
| +35% | +$464K |
|
|
IMLP
2465
DELISTED
iPath S&P MLP ETN
IMLP
| $1.74M | ﹤0.01% |
140,000
| – | – |
|
|
WWE
2466
DELISTED
World Wrestling Entertainment
WWE
| $1.74M | ﹤0.01% |
35,202
-529
| -1% | -$28.8K |
|
2467
Universal Corp
UVV
$1.31B
| $1.74M | ﹤0.01% |
31,610
+10,942
| +53% | +$545K |
|
2468
Standex International
SXI
$3.59B
| $1.73M | ﹤0.01% |
15,644
+5,120
| +49% | +$556K |
|
2469
Natera
NTRA
$38.3B
| $1.73M | ﹤0.01% |
18,511
-11,069
| -37% | -$1.15M |
|
|
HEES
2470
DELISTED
H&E Equipment Services
HEES
| $1.73M | ﹤0.01% |
39,042
+4,689
| +14% | +$205K |
|
2471
National Grid
NGG
$80.4B
| $1.72M | ﹤0.01% |
26,485
-41,007
| -61% | -$2.41M |
|
2472
Zumiez
ZUMZ
$332M
| $1.72M | ﹤0.01% |
35,916
+4,161
| +13% | +$190K |
|
|
ZNGA
2473
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $1.72M | ﹤0.01% |
269,300
+183,400
| +214% | +$1.27M |
|
2474
Laureate Education
LAUR
$5.28B
| $1.72M | ﹤0.01% |
140,463
-19,830
| -12% | -$260K |
|
2475
Ranpak Holdings
PACK
$439M
| $1.72M | ﹤0.01% |
45,651
+22,677
| +99% | +$800K |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.